Navigating electronic prior authorization (ePA) requirements can be a major blind spot for biopharmaceutical teams, especially in rare disease therapies where coverage criteria are often unclear, inconsistent, or difficult to access. In this case study, we explore how Policy Reporter and Valeris Hub worked together to bring clarity to a fragmented landscape by consolidating ePA question sets, payer policies, and prior authorization forms into a single, structured source of truth.

By uncovering gaps, discrepancies, and missing documentation across payers, this approach provided unprecedented visibility into coverage requirements and decision pathways. The result? Fewer denials, stronger and more informed appeals, and faster access for patients. Download the full case study to see how enhanced access intelligence can transform your reimbursement strategy and improve outcomes across your patient support programs.